𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comment on ‘Predicting recurrence in axillary node negative breast cancer patients’, by Rosner and Lane

✍ Scribed by MH Galea; RW Blamey

Publisher
Springer US
Year
1993
Tongue
English
Weight
88 KB
Volume
28
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact on regional recurrence and surviv
Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer
✍ C. K. Axelsson; M. Düring; P. M. Christiansen; P. A. Wamberg; K. L. Søe; S. Møll 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## Abstract ## Background This study examined whether axillary lymph node dissection (ALND) with removal of many normal lymph nodes resulted in a reduced rate of axillary recurrence and better survival, as reported in recent studies. ## Methods The follow-up analyses were based on 8657 patients

Impact of axillary lymph node dissection
Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients : A Systematic Review and Meta-Analysis
✍ Mona Sanghani; Ethan M. Balk; Blake Cady 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients

The prognostic significance of the perce
The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes
✍ Pauline T. Truong; Eric Berthelet; Junella Lee; Hosam A. Kader; Ivo A. Olivotto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Abstract ## BACKGROUND Adjuvant therapy for women with T1–T2 breast carcinoma and 1–3 positive lymph nodes is controversial due to discrepancies in reported baseline locoregional recurrence (LRR) risks. This inconsistency has been attributed to variations in lymph node staging techniques, which